Related Experiment Video
Updated: May 25, 2026

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage
Published on: August 21, 2021
Balancing repair and tolerance of DNA damage caused by alkylating agents
Dragony Fu1, Jennifer A Calvo, Leona D Samson
1Department of Biological Engineering, Center for Environmental Health Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
Abstract:
Alkylating agents constitute a major class of frontline chemotherapeutic drugs that inflict cytotoxic DNA damage as their main mode of action, in addition to collateral mutagenic damage. Numerous cellular pathways, including direct DNA damage reversal, base excision repair (BER) and mismatch repair (MMR), respond to alkylation damage to defend against alkylation-induced cell death or mutation. However, maintaining a proper balance of activity both within and between these pathways is crucial for a favourable response of an organism to alkylating agents. Furthermore, the response of an individual to alkylating agents can vary considerably from tissue to tissue and from person to person, pointing to genetic and epigenetic mechanisms that modulate alkylating agent toxicity.
Insights
Alkylating agents cause DNA damage, but cellular repair pathways like base excision repair (BER) and mismatch repair (MMR) can mitigate this. Balancing these repair pathways is key to effective chemotherapy and reducing toxicity.
Area of Science:
- Molecular Biology
- Genetics
- Pharmacology
Background:
- Alkylating agents are crucial chemotherapy drugs.
- They induce cytotoxic and mutagenic DNA damage.
- Cellular repair mechanisms counteract this damage.
Purpose of the Study:
- To investigate the role of DNA repair pathways in response to alkylating agents.
- To understand how pathway balance affects chemotherapy outcomes.
- To explore factors influencing individual variability in drug toxicity.
Main Methods:
- Review of cellular DNA repair pathways (direct reversal, BER, MMR).
- Analysis of the impact of pathway activity on cell death and mutation.
- Discussion of genetic and epigenetic modulation of drug response.
Main Results:
- Proper balance within and between DNA repair pathways is essential.
- Imbalances can lead to unfavorable responses to alkylating agents.
- Individual responses vary due to genetic and epigenetic factors.
Conclusions:
- Cellular defense against alkylating agents relies on a delicate balance of DNA repair.
- Modulating these pathways could optimize chemotherapy efficacy.
- Understanding individual variability is critical for personalized treatment.
Related Concept Videos
Overview of DNA Repair
Chemically...
Overview of DNA Repair
Chemically...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Base Excision Repair
The first step of...
Base Excision Repair
The first step of...

